查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786929

胃癌诊断药市场，规模，占有率，趋势，产业分析报告:各产品类型，各疾病类型，各最终用途，各地区 - 市场预测，2025～2034年

Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，全球胃癌诊断市场规模预计到 2034 年将达到 27.8 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

胃癌诊断市场专注于用于检测和确诊胃癌的各种方法和技术。这包括医疗保健专业人员使用的各种医学检测、程序和评估，以便及早发现疾病、确定其扩散并制定适当的治疗方案。这些诊断方法包括影像学检查、内视镜检查、组织活检、血液检测和先进的分子分析，旨在提供准确及时的诊断。

胃癌诊断市场的成长是由全球胃癌病例数量的增加所推动的，这自然促使对诊断服务的需求增加。此外，癌症的早期发现通常可以带来成功的治疗，因此人们越来越重视透过筛检计画进行早期发现。该行业也受益于持续的技术进步，这些进步带来了更新、更准确、侵入性更低的诊断工具，有助于更有效地识别疾病并根据个别患者制定个人化治疗方案。

胃癌诊断市场报告重点

按产品划分，试剂和耗材细分市场预计将在2024年占最大的市场占有率，因为试剂和耗材对于几乎所有诊断测试都至关重要，从常规血液检测到高级分子分析。

按疾病类型划分，腺癌是迄今为止最常见的胃癌类型，在2024年占了最大的市场占有率。自然而然，大多数诊断工作和资源分配都用于识别和表征这种广泛传播的疾病亚型。

按最终用途划分，预计医院领域将在 2024 年占最大的市场占有率。医院是主要的医疗保健机构，患者通常在此接受初步诊断、内视镜检查以及综合诊断基础设施。

由于北美拥有先进的医疗基础设施、对早期诊断的高度重视以及对精准医疗的浓厚兴趣，预计北美胃癌诊断市场将在 2024 年占最大占有率。受全球（尤其是东亚国家）高胃癌发生率的推动，亚太市场正在迅速扩张。

该市场的主要公司包括罗氏公司 (F. Hoffmann-La Roche Ltd.)、雅培实验室 (Abbott Laboratories)、凯杰公司 (QIAGEN)、伯乐实验室 (Bio-Rad Laboratories, Inc.)、安捷伦科技公司 (Agilent Technologies, Inc.)、Illumina, Inc., P. Diagnostics、BIOMERIEUX 与 AI Medical Service Inc.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球胃癌诊断市场洞察

  • 市场概述
  • 胃癌诊断市场动态
    • 促进因素和机会
      • 全球胃癌发生率上升
      • 诊断技术的进步
    • 限制因素与挑战
      • 早期检测方法有限
  • PESTEL分析
  • 胃癌诊断市场应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球胃癌诊断市场:各产品

  • 主要调查结果
  • 简介
  • 试剂与消耗品
  • 设备

第6章 全球胃癌诊断市场:各疾病类型

  • 主要调查结果
  • 简介
  • 腺癌症
  • 胃淋巴瘤
  • 其他

第7章 全球胃癌诊断市场:各最终用途

  • 主要调查结果
  • 简介
  • 医院
  • 诊断检验室
  • 诊断影像

第8章 全球胃癌诊断市场:地区

  • 主要调查结果
  • 简介
    • 胃癌诊断市场分析:地区，2020年～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各疾病，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各疾病，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:疾病类别，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:疾病类别，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:疾病类别，2020-2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • AI Medical Service Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Mirxes Pte. Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN
  • Vela Diagnostics
Product Code: PM5915

The global gastric cancer diagnostics market size is expected to reach USD 2.78 billion by 2034, according to a new study by Polaris Market Research. The report "Gastric Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Consumables, Instruments), By Disease Type, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The gastric cancer diagnostics market focuses on the various methods and technologies used to detect and confirm stomach cancer. This involves a range of medical tests, procedures, and evaluations that healthcare professionals use to identify the disease in its early stages, determine its spread, and guide appropriate treatment plans. These diagnostic approaches include imaging studies, endoscopic examinations, tissue biopsies, blood tests, and advanced molecular analyses, all aimed at providing an accurate and timely diagnosis.

The gastric cancer diagnostics market growth is attributed to the increasing number of gastric cancer cases around the world, which naturally leads to a higher demand for diagnostic services. Additionally, there is a growing emphasis on early detection through screening programs, as finding the cancer early often improves treatment success. The industry is also benefiting from ongoing technological advancements, with newer, more precise, and less invasive diagnostic tools becoming available, which helps identify the disease more effectively and tailoring treatments to individual patients.

Gastric Cancer Diagnostics Market Report Highlights

By product, the reagents & consumables segment held the largest share in 2024 as reagents and consumables are essential for almost every diagnostic test, from routine blood work to advanced molecular analyses.

By disease type, the adenocarcinoma segment held the largest share in 2024, due to its overwhelming prevalence as the most common form of gastric cancer. The majority of diagnostic efforts and resource allocation are naturally directed toward identifying and characterizing this widespread disease type.

By end use, the hospitals segment held the largest share in 2024 as they are the primary healthcare facilities where patients typically receive initial diagnoses, undergo endoscopic procedures, and access comprehensive diagnostic infrastructure.

The North America gastric cancer diagnostics market accounted for the largest share in 2024, due to advanced healthcare infrastructure, high awareness regarding early diagnosis, and a strong focus on precision medicine. The market in Asia Pacific is expanding rapidly, driven by the highest global incidence of gastric cancer, particularly in East Asian countries.

A few key players in the market include F. Hoffmann-La Roche Ltd.; Abbott Laboratories; QIAGEN; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Illumina, Inc.; Myriad Genetics, Inc.; Mirxes Pte. Ltd.; Vela Diagnostics; BIOMERIEUX; and AI Medical Service Inc.

Polaris Market Research has segmented the gastric cancer diagnostics market report on the basis of product, disease type, end use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Reagents & Consumables

Instruments

By Disease Type Outlook (Revenue - USD Billion, 2020-2034)

Adenocarcinoma

Gastric lymphoma

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Diagnostic Laboratories

Diagnostic Imaging

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Gastric Cancer Diagnostics Market Insights

  • 4.1. Gastric Cancer Diagnostics Market - Market Snapshot
  • 4.2. Gastric Cancer Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Incidence of Gastric Cancer
      • 4.2.1.2. Advancements in Diagnostic Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited early detection methods
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gastric Cancer Diagnostics Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gastric Cancer Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Reagents & Consumables
    • 5.3.1. Global Gastric Cancer Diagnostics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Gastric Cancer Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)

6. Global Gastric Cancer Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • 6.3. Adenocarcinoma
    • 6.3.1. Global Gastric Cancer Diagnostics Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
  • 6.4. Gastric lymphoma
    • 6.4.1. Global Gastric Cancer Diagnostics Market, by Gastric lymphoma, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gastric Cancer Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
  • 7.5. Diagnostic Imaging
    • 7.5.1. Global Gastric Cancer Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Gastric Cancer Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gastric Cancer Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Gastric Cancer Diagnostics Market - North America
    • 8.3.1. North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Gastric Cancer Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Gastric Cancer Diagnostics Market - Canada
      • 8.3.5.1. Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Gastric Cancer Diagnostics Market - Europe
    • 8.4.1. Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Gastric Cancer Diagnostics Market - UK
      • 8.4.4.1. UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Gastric Cancer Diagnostics Market - France
      • 8.4.5.1. France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Gastric Cancer Diagnostics Market - Germany
      • 8.4.6.1. Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Gastric Cancer Diagnostics Market - Italy
      • 8.4.7.1. Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Gastric Cancer Diagnostics Market - Spain
      • 8.4.8.1. Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Gastric Cancer Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Gastric Cancer Diagnostics Market - Russia
      • 8.4.10.1. Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Gastric Cancer Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Gastric Cancer Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Gastric Cancer Diagnostics Market - China
      • 8.5.4.1. China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Gastric Cancer Diagnostics Market - India
      • 8.5.5.1. India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Gastric Cancer Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Gastric Cancer Diagnostics Market - Japan
      • 8.5.7.1. Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Gastric Cancer Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Gastric Cancer Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Gastric Cancer Diagnostics Market - Australia
      • 8.5.10.1. Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Gastric Cancer Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Gastric Cancer Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Gastric Cancer Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Gastric Cancer Diagnostics Market - UAE
      • 8.6.5.1. UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Gastric Cancer Diagnostics Market - Israel
      • 8.6.6.1. Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Gastric Cancer Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Gastric Cancer Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Gastric Cancer Diagnostics Market - Latin America
    • 8.7.1. Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Gastric Cancer Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Gastric Cancer Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Gastric Cancer Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Gastric Cancer Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AI Medical Service Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BIOMERIEUX
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bio-Rad Laboratories, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mirxes Pte. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. QIAGEN
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Vela Diagnostics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 3 Global Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 6 North America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 9 U.S.: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 12 Canada: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 15 Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 18 UK: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 21 France: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 24 Germany: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 27 Italy: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 36 Russia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 45 China: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 48 India: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 54 Japan: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 60 South Korea: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 63 Australia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 75 UAE: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 78 Israel: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 81 South Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 87 Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 90 Mexico: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 93 Brazil: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 96 Argentina: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Gastric Cancer Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Gastric Cancer Diagnostics Market, by Disease Type, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Gastric Cancer Diagnostics Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Gastric Cancer Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Gastric Cancer Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Disease Type
  • Figure 9. Global Gastric Cancer Diagnostics Market, by Disease Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Gastric Cancer Diagnostics Market, by End Use, 2024 & 2034 (USD Billion)